Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04882488

Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis

Correlation of FFR and iFR With Cardiac PET Perfusion (at Rest and Under Adenosine) in the Evaluation of Intermediate Coronary Stenoses in Patients With Severe Aortic Valve Stenosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Heart and Diabetes Center North-Rhine Westfalia · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Aortic valve stenosis (AS) affects 2-7% of persons \> 65 years, symptoms include: angina and dyspnea, dizziness and syncope. Coincidence of coronary artery disease (CAD), also presenting with angina and dyspnea, in patients with AS between 40 - 65% . Angina in AS caused by significant reduction of coronary flow reserve (CFR). CFR is the ratio of maximal flow increase in the coronary vessel bed during maximal hyperaemia (medically or exercise induced). FFR (fractional flow reserve) use in patients with AS potentially invalid due to dysfunctional CFR leading to potential undertreatment of CAD in these patients.CFR disturbance in AS mainly due to myocardial overload causing concentric hypertrophy, increased oxygen consumption and neurohormonal activation leading to increased vascular resistance. Current studies are investigating the validity of FFR and iFR in AS patients. Recent data demonstrate very good correlation between FFR and iFR derived values to PET myocardial perfusion imaging values in patients with no evidence of AS. Our study aims to investigate the diagnostic performance of FFR and iFR in intermediate-grade coronary stenosis in patients with severe aortic valve disease and correlate FFR- and iFR derived values with those extracted from PET-perfusion Imaging.

Conditions

Timeline

Start date
2021-06-01
Primary completion
2025-06-30
Completion
2025-09-30
First posted
2021-05-12
Last updated
2024-11-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04882488. Inclusion in this directory is not an endorsement.